Utah Medical Products, Inc. (FRA:UTM)
Germany
· Delayed Price · Currency is EUR 46.20
-0.20 (-0.43%)
Last updated: Dec 3, 2025, 8:01 AM CET
Utah Medical Products Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 154 | 201 | 277 | 341 | 321 | 251 | Upgrade
|
| Market Cap Growth | -25.56% | -27.18% | -18.96% | 6.29% | 27.96% | -29.88% | Upgrade
|
| Enterprise Value | 82 | 116 | 197 | 277 | 265 | 213 | Upgrade
|
| Last Close Price | 46.80 | 56.59 | 74.90 | - | - | - | Upgrade
|
| PE Ratio | 15.57 | 15.03 | 18.38 | 22.14 | 24.69 | 28.42 | Upgrade
|
| PS Ratio | 4.68 | 5.10 | 6.09 | 6.98 | 7.44 | 7.28 | Upgrade
|
| PB Ratio | 1.53 | 1.78 | 2.38 | 3.19 | 3.41 | 2.99 | Upgrade
|
| P/TBV Ratio | 1.76 | 2.07 | 2.79 | 4.03 | 4.85 | 4.75 | Upgrade
|
| P/FCF Ratio | 13.04 | 14.28 | 14.12 | 17.93 | 17.68 | 15.92 | Upgrade
|
| P/OCF Ratio | 12.79 | 14.06 | 13.72 | 17.25 | 17.22 | 15.24 | Upgrade
|
| EV/Sales Ratio | 2.47 | 2.94 | 4.34 | 5.65 | 6.14 | 6.19 | Upgrade
|
| EV/EBITDA Ratio | 5.89 | 6.49 | 8.80 | 11.02 | 11.51 | 12.50 | Upgrade
|
| EV/EBIT Ratio | 7.23 | 7.65 | 11.81 | 14.93 | 15.95 | 19.04 | Upgrade
|
| EV/FCF Ratio | 6.93 | 8.24 | 10.06 | 14.53 | 14.58 | 13.54 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Debt / FCF Ratio | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Asset Turnover | 0.31 | 0.32 | 0.39 | 0.44 | 0.43 | 0.38 | Upgrade
|
| Inventory Turnover | 1.92 | 1.82 | 2.19 | 2.61 | 2.83 | 2.53 | Upgrade
|
| Quick Ratio | 29.22 | 23.18 | 20.44 | 13.52 | 17.65 | 14.69 | Upgrade
|
| Current Ratio | 32.06 | 25.64 | 22.56 | 15.09 | 19.54 | 16.42 | Upgrade
|
| Return on Equity (ROE) | 9.59% | 11.29% | 13.72% | 14.88% | 14.09% | 10.59% | Upgrade
|
| Return on Assets (ROA) | 6.56% | 7.62% | 8.89% | 10.33% | 10.38% | 7.74% | Upgrade
|
| Return on Capital (ROIC) | 6.79% | 7.98% | 9.48% | 11.14% | 11.20% | 8.37% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.10% | 13.20% | 14.10% | 16.80% | 16.90% | 12.70% | Upgrade
|
| Earnings Yield | 6.42% | 6.65% | 5.44% | 4.52% | 4.05% | 3.52% | Upgrade
|
| FCF Yield | 7.67% | 7.00% | 7.08% | 5.58% | 5.66% | 6.28% | Upgrade
|
| Dividend Yield | 2.37% | 2.06% | 1.43% | - | - | - | Upgrade
|
| Payout Ratio | 34.80% | 30.70% | 25.74% | 19.20% | 77.53% | 38.12% | Upgrade
|
| Buyback Yield / Dilution | 7.79% | 3.68% | 0.16% | 0.46% | 0.33% | 1.79% | Upgrade
|
| Total Shareholder Return | 10.16% | 5.74% | 1.59% | 0.46% | 0.33% | 1.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.